Indeed, the first and also the primary drugs approved by FDA for the symptomatic treatment of AD are AChEIs, which partly restore the cholinergic dysfunction by inhibiting AChE to increase the acetylcholine levels. The gene discussed is ACHE; the disease is Alzheimer disease.